Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.
about
Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist PerspectiveThe role of alpha-7 nicotinic receptors in food intake behaviorsA review of experimental evidence linking neurotoxic organophosphorus compounds and inflammationHeteromeric α7β2 Nicotinic Acetylcholine Receptors in the BrainRenoprotective effects of long-term oral nicotine in a rat model of spontaneous proteinuriaAnti-inflammatory effects of the nicotinergic peptides SLURP-1 and SLURP-2 on human intestinal epithelial cells and immunocytesInflammation: The Common Pathway of Stress-Related Diseases.Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistanceTargeting anti-inflammatory treatment can ameliorate injury-induced neuropathic pain.Discontinued in 2013: diabetic drugs.The role of α7 nicotinic acetylcholine receptor in modulation of heart rate dynamics in endotoxemic rats.Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.Design and Synthesis of Nicotinic Acetylcholine Receptor Antagonists and their Effect on Cognitive Impairment.α7 nicotinic acetylcholine receptor (α7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex.Nicotinic alpha 7 receptor expression and modulation of the lung epithelial response to lipopolysaccharide.Neural circuitry and immunity.Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Non-Obese Diabetic MiceNicotinic regulation of energy homeostasis.Cholinergic connectivity: it's implications for psychiatric disorders.Effects of dietary supplementation with the solanaceae plant alkaloid anatabine on joint pain and stiffness: results from an internet-based survey studyMultiple modes of α7 nAChR noncompetitive antagonism of control agonist-evoked and allosterically enhanced currents.The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface.Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trialThe Protective Effect of Alpha 7 Nicotinic Acetylcholine Receptor Activation on Critical Illness and Its MechanismThe therapeutic promise of positive allosteric modulation of nicotinic receptors.Anti-inflammatory effects of nicotine in obesity and ulcerative colitis.Acetylcholine and the alpha 7 nicotinic receptor: a potential therapeutic target for the treatment of periodontal disease?The vagal innervation of the gut and immune homeostasisPET tracers for imaging brain α7 nicotinic receptors: an update.Specific α7 nicotinic acetylcholine receptor agonist ameliorates isoproterenol-induced cardiac remodeling in mice through TGF-β1/Smad3 pathway.Vagal Modulation of the Inflammatory Response in Sepsis.Beyond the 5-HT3 receptors: A role for α7nACh receptors in neuroprotective aspects of tropisetron.Synovial membrane receptors as therapeutic targets: A review of receptor localization, structure, and function.[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.Neural control of the immune system.Calcium imaging with genetically encoded sensor Case12: Facile analysis of α7/α9 nAChR mutants.Vagotomy affects the development of oral tolerance and increases susceptibility to develop colitis independently of the alpha-7 nicotinic receptor.A G protein-coupled α7 nicotinic receptor regulates signaling and TNF-α release in microgliaExpression and Functional Role of α7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) CellsSystemic administration of an alpha-7 nicotinic acetylcholine agonist reverses neuropathic pain in male Sprague Dawley rats.
P2860
Q26774441-5A3B419A-E257-4D52-9E28-21FAAC899755Q26830298-B8AEB1E1-5D60-467D-8A28-B2105A0E4628Q27022179-22FBD1B0-B949-4509-BD54-DACB3B54D817Q28066040-DF7A6660-E12F-49BD-9E82-CD4E4BF7E7F3Q28583340-ACE5B0AB-00C4-49B9-A0D4-038177B33792Q33625260-25B27241-3004-4DE9-9727-058A62D7011CQ33813364-7B0DBD78-0410-4325-B5D9-17CF21274366Q34578490-AAD70E83-95A3-430B-841C-BAF150528BB7Q34612387-8FF78434-2784-4A30-9856-1A05962DD150Q34664870-40659EA4-F031-45A4-A1CA-8FD18CE6FB20Q35067730-0627BA1F-0AC6-42B5-AD00-DF637775FAC0Q35182164-5B30A289-7BE4-48DA-82F5-F526340431BCQ35733853-99C2C9E7-937E-427A-BF86-68E8B725BAB8Q35973244-48171D85-17A8-4556-9870-AC2983530F2CQ36338452-183F1FF8-D87E-4C3E-8D87-6BC8AC65FB70Q36551920-1B4B79F7-99E3-447B-ABC0-FEA113B32191Q36568311-867E6D35-E7EB-45D9-B109-091C1C8F2BD4Q36727840-3C79A0BC-7A79-442F-B969-C8FEEA172F50Q36812599-EB6FB9AE-F942-4226-8FAA-7D205B8A083DQ37302467-E3DFE04A-1E69-45EA-B99A-E40681E1773BQ37422762-AB60EA78-B8DB-4D54-AE29-CA14DB5B86E4Q37583624-0F065B3A-C943-4C74-B265-9FC1064A9243Q37592815-635CAEB1-E570-4BFA-851E-1C0F98987285Q37604595-CD93AAFE-4DF9-4320-971B-C532D20A3C64Q37695734-8C942E84-2C42-4C46-B516-0AA327247009Q37910318-A1A816CE-0966-441B-9386-ED23B71212F0Q38024970-4669FA09-2774-49EC-8109-43216F668475Q38047774-45A5F8EE-744B-44C6-84E3-1729DE32471FQ38584762-D2560ABE-2143-455E-9793-5C7BFBE4FAB3Q38667881-1258185D-40A4-41E7-B9BD-236F800BF704Q38820780-FAB69205-F054-4A4B-B576-8BF1FD0FF22CQ38842795-C7590925-4318-4E80-B8D3-DF015FE6E84DQ39218577-A96EED95-230F-48B8-99DE-4B92B110D900Q39294038-6D3A80E6-415A-42C4-9E31-13EB9E4C3EC1Q40659863-438AF071-6123-4FB0-AABD-0BD192A2BABBQ41349051-34B341FB-BAE9-447E-9F3C-8E12C6768C22Q41517533-64B5F563-8021-4C45-A051-C615BB7BF3D3Q41627685-B9CA3D13-57E0-445C-9AE6-645FF9BF015EQ42380131-41F0EB17-FAF4-4380-AD69-DA71EA00D285Q42641863-64AFE773-8C6C-454C-9082-BA09F68C9450
P2860
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.
@en
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.
@nl
type
label
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.
@en
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.
@nl
prefLabel
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.
@en
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.
@nl
P2093
P2860
P1476
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.
@en
P2093
Mario B Marrero
Merouane Bencherif
Patrick M Lippiello
P2860
P2888
P304
P356
10.1007/S00018-010-0525-1
P50
P577
2010-10-15T00:00:00Z